Late presentation of acromegaly in medically controlled prolactinoma patients
Co-secretion of growth hormone (GH) and prolactin (PRL) from a single pituitary adenoma is common. In fact, up to 25% of patients with acromegaly may have PRL co-secretion. The prevalence of acromegaly among patients with a newly diagnosed prolactinoma is unknown. Given the possibility of mixed GH a...
Main Authors: | Ekaterina Manuylova, Laura M Calvi, Catherine Hastings, G Edward Vates, Mahlon D Johnson, William T Cave Jr, Ismat Shafiq |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2016-10-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-16-0069 |
Similar Items
-
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
by: Bonert Vivien S, et al.
Published: (2010-05-01) -
Prolactinomas: Aspectos neurocirúrgicos Prolactinomas: neurosurgical aspects
by: Oswaldo Inácio Tella Jr, et al.
Published: (2002-03-01) -
Medical Therapy of Acromegaly
by: U. Plöckinger
Published: (2012-01-01) -
Combined surgical and medical treatment of giant prolactinoma
by: Mugurel Rădoi, et al.
Published: (2016-06-01) -
Orbital Pseudotumor in a Patient Treated With Zoledronic Acid: A Case Report and Pertinent Literature Review
by: Ekaterina Manuylova, MD, et al.
Published: (2016-01-01)